Superworth

Prestige Consumer Healthcare profit margin PBH

Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.

Net margin, 12 months
15.6%
Operating margin, 12 months
26.3%
Net margin on a year earlier
−3.4 pts
Peer median
11.1%

Over the twelve months to Jun 30, 2026, Prestige Consumer Healthcare kept 15.6% of its revenue as net profit, with an operating margin of 26.3% and a gross margin of 53.5%.

Five years earlier its net margin was 18.2%.

The median for 10 large drugmakers of a similar size is 11.1%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY202617.5%28.4%54.7%
FY202518.9%29.6%55.8%
FY202418.6%30.4%55.5%
FY2023−7.3%−2.0%55.4%
FY202218.9%30.4%57.1%
FY202117.5%31.5%58.0%
FY202014.8%30.2%57.3%
FY2019−3.7%6.9%56.9%
FY201832.6%20.7%55.4%
FY20177.9%23.3%56.7%
FY201612.4%32.3%57.9%
FY201511.0%29.0%56.8%
FY201412.2%31.6%56.2%
FY201310.5%30.8%55.7%
FY20128.4%23.3%51.6%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q1 FY2715.6%−3.4 pts26.3%
Q4 FY2617.5%−1.4 pts28.4%
Q3 FY2616.9%−2.2 pts29.2%
Q2 FY2618.1%−0.5 pts29.9%
Q1 FY2619.0%+0.6 pts30.0%
Q4 FY2518.9%+0.3 pts29.6%
Q3 FY2519.1%+26.2 pts29.6%
Q2 FY2518.5%+25.8 pts29.3%
Q1 FY2518.4%+25.9 pts29.6%
Q4 FY2418.6%+25.9 pts30.4%
Q3 FY24−7.1%−26.1 pts−1.8%
Q2 FY24−7.3%−26.1 pts−1.8%

Against its peers

Companies in Drug Manufacturers - General nearest Prestige Consumer Healthcare's size, closest first, today.

CompanyProfit margin
PBHPrestige Consumer Healthcare15.6%
HRMYHarmony Biosciences18.9%
NRIXNurix Therapeutics42.0%
ANIPANI Pharmaceuticals11.1%
PAHCPhibro Animal Health6.6%
ANABAnaptysbion/m
PCRXPacira BioSciences2.0%
OGNOrganon3.4%
LQDALiquidia30.7%
ARQTArcutis Biotherapeutics6.1%
INDVIndivior Pharmaceuticals26.7%
Peer median11.1%

Where Prestige Consumer Healthcare ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Prestige Consumer Healthcare

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.